Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: Tokyo
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

OncoTherapy Science Inc

+ Add to Watchlist

4564:JP

297,000 JPY 19,500 6.16%

As of 02:00:00 ET on 05/22/2013.

Company Profile for OncoTherapy Science Inc (4564)

OncoTherapy Science Inc., is a biopharmaceutical company. The Company conducts research & development of medicine, treatments, and gene-analysis on cancer.

Contact Information

OncoTherapy Science Inc

3-2-1 Sakado
Takatsu-ku Kawasaki
Kanagawa, 213-0012
Japan
Phone: 81-4-4820-8251
Fax: 81-4-4820-8260

Key Executives for OncoTherapy Science Inc (4564)

Takuya TsunodaPresidentKazuo YamamotoDirector
Hiroshi YamajiDirector

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil